NKX2–2, a homeodomain transcription factor involved in neuroendocrine/glial differentiation and a downstream target of EWSR1-FLI1, has been reported as an immunohistochemical marker for Ewing sarcoma [39]. This evidence concerns the gene FLI1 and Ewing sarcoma.